PROPHYLACTIC USE OF ALLOPATHIC, COMPLEMENTARY & ALTERNATIVE MEDICINE (CAM) FOR COVID-19: A CROSS SECTIONAL SURVEY AMONG MEDICAL POST-GRADUATES OF TERTIARY CARE TEACHING HOSPITALS, GUJARAT
-
Published:2022-11-01
Issue:
Volume:
Page:6-8
-
ISSN:
-
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
-
language:en
-
Short-container-title:ijsr
Author:
DK Patel1, KG Piparva2, AP Singh3
Affiliation:
1. 3 year Resident doctor, Department of Pharmacology, PDU Govt. Medical College, Rajkot, India -360001 2. Assistant Professor, Department of Pharmacology, All India Institute of Medical College (AIIMS), Rajkot, India - 360001 3. Professor and Head, Department of Pharmacology, PDU Govt. Medical College, Rajkot, India -360001
Abstract
Introduction: COVID-19 infection was declared a global pandemic and public health emergency by WHO. In order to avoid getting infected with
the virus, various preventive measures were followed including prophylactic medicine, particularly among health care professional working with
patients. The current study aimed to evaluate pattern of prophylactic medicines consumed by post graduate doctors for prevention of COVID-19
infection. Methodology: A prospective cross-sectional study was conducted among the post graduate resident doctors (1st year to 4th year) of
various medical specialties working in COVID-19 at various tertiary care teaching hospitals across Gujarat. A questionnaire regarding
prophylactic use of medicine was communicated through online tool. Results: Of 311 respondents, mean age was 28±2 years and male to female
ratio was 0.94. 8% participants have history of recurrent respiratory infection. Out of 311 participants 233 (74.91%) consumed prophylaxis. Most
commonly consumed prophylactic medicine was of allopathy (64%) followed by Complementary & alternative medicine and home remedies
(63.02%). Vitamin C (56.27%), Multivitamins (33.11%), Zinc (27%), Azithromycin (21.86%), Hydroxychloroquine (16.72%) were most
frequently consumed allopathic medicines. Turmeric (53.06%), Ayurvedic kadha (44.38%), lemon (43.36%) were frequently consumed CAM and
home remedies. 20 participants reported Adverse Drug Reactions (ADRs) in which common ADRs nausea (65%) and Diarrhea (50%). 59.16 %
participants developed COVID-19 out of 51.63 % participants had COVID-19 after taking prophylaxis. Occurrence of COVID-19 infection
among post-Graduate doctors was not signicantly associated with prophylactic use of medicine. Conclusion: Vitamins, zinc, azithromycin and
hydroxychloroquine (allopathic medicines) and turmeric and ayurvedic kadha (CAM) were commonly used prophylactic medicines. Occurrence
of COVID-19 infection was not signicantly associated with intake of prophylactic medicine
Publisher
World Wide Journals
Subject
General Economics, Econometrics and Finance,General Social Sciences,Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Multidisciplinary,General Chemical Engineering,Law,Surfaces, Coatings and Films,General Energy,Mechanical Engineering,Industrial and Manufacturing Engineering,Strategy and Management,Computer Science Applications,Industrial relations,Management Information Systems,Marketing,General Engineering,Developmental and Educational Psychology,Education,Engineering (miscellaneous),Instrumentation
Reference30 articles.
1. Charan, J, Bhardwaj, P, Kaur, R, Bist, S, Detha, M. Use of complementary and alternative medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey. Ind J Clin Biochem. [Online] 2021; 36 (1): 108-111. Available from: https://doi org/10.1007/s12291-020-00931-4 [Accessed 20 September 2021]. 2. Paudyal, V, sun, S, Hussain, R, Auutaleb, M, Hedima, E. Complementary and alternative medicines use in COVID-19: A global perspective on practice,policy and research. Elsevier Inc. [Online] 2021; 10 (1016): 1551-7411. Available from: https://doi.org/10.1016/j.sapharm.2021.05.004 [Accessed 20 September 2021]. 3. Haung, J, Tao, G, Liu, J. Current prevention of COVID-19: Natural products and herbal Medicine. Front Pharmacol. [Online] 2020; 11(588508): 1-18. Available from: doi : 10.3389/phar.2020.588508 [Accessed 3 February 2022]. 4. Ben-Zuk, N.; Dechtman, I.-D.; Henn, I.; Weiss, L.; Afriat, A.; Krasner, E.; Gal, Y. Potential Prophylactic Treatments for COVID-19. Viruses 2021, 13, 1292. https://doi.org/10.3390/v13071 5. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/ emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-thevirus-that-causes-it. [Accessed 13 february 2022]
|
|